Ann S. Knoop

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

Benefit of adjuvant chemotherapy in patients with T1a-bN0, triple-negative breast cancer - A systematic review and meta-analysis.

Benefit of adjuvant chemotherapy in patients with T1a-bN0, triple-negative breast cancer - A systematic review and meta-analysis.

Journal: Critical reviews in oncology/hematology

Published: January 03, 2026

Real-world efficacy of tucatinib in Danish human epidermal growth factor receptor 2-positive metastatic breast cancer.

Real-world efficacy of tucatinib in Danish human epidermal growth factor receptor 2-positive metastatic breast cancer.

Journal: Danish medical journal

Published: October 10, 2025

Dietary Supplement Use and Life Expectancy After Breast Cancer-The Danish Diet, Cancer and Health Cohort.

Dietary Supplement Use and Life Expectancy After Breast Cancer-The Danish Diet, Cancer and Health Cohort.

Journal: The Journal of nutrition

Published: July 01, 2025

Impact of age and comorbidities on real-world outcomes in advanced breast cancer patients treated with palbociclib in first line: a nation-wide Danish retrospective study.

Impact of age and comorbidities on real-world outcomes in advanced breast cancer patients treated with palbociclib in first line: a nation-wide Danish retrospective study.

Journal: Acta oncologica (Stockholm, Sweden)

Published: February 21, 2025

Comprehensive mapping elucidates high risk genotypes in primary metastatic breast cancer.

Comprehensive mapping elucidates high risk genotypes in primary metastatic breast cancer.

Journal: Neoplasia (New York, N.Y.)

Published: January 28, 2025

Adjuvant Docetaxel and Cyclophosphamide With or Without Epirubicin for Early Breast Cancer: Final Analysis of the Randomized DBCG 07-READ Trial.

Adjuvant Docetaxel and Cyclophosphamide With or Without Epirubicin for Early Breast Cancer: Final Analysis of the Randomized DBCG 07-READ Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 23, 2024

Chronic chemotherapy-induced peripheral neuropathy and pain following paclitaxel versus docetaxel in breast cancer survivors: A cross-sectional study.

Chronic chemotherapy-induced peripheral neuropathy and pain following paclitaxel versus docetaxel in breast cancer survivors: A cross-sectional study.

Journal: Breast (Edinburgh, Scotland)

Published: October 21, 2024

Outcomes based on risk-adapted adjuvant therapy in postmenopausal women with early breast cancer: a nationwide, prospective cohort study by the Danish Breast Cancer Group.

Outcomes based on risk-adapted adjuvant therapy in postmenopausal women with early breast cancer: a nationwide, prospective cohort study by the Danish Breast Cancer Group.

Journal: The Lancet. Oncology

Published: August 27, 2024

Survival outcomes for HER2-low breast cancer: Danish national data.

Survival outcomes for HER2-low breast cancer: Danish national data.

Journal: Acta oncologica (Stockholm, Sweden)

Published: August 04, 2024

Safety of topical estrogen therapy during adjuvant endocrine treatment among patients with breast cancer: A meta-analysis based expert panel discussion.

Safety of topical estrogen therapy during adjuvant endocrine treatment among patients with breast cancer: A meta-analysis based expert panel discussion.

Journal: Cancer treatment reviews

Published: August 03, 2024

Overall survival after CDK4/6 inhibitor dose reduction in women with metastatic breast cancer.

Overall survival after CDK4/6 inhibitor dose reduction in women with metastatic breast cancer.

Journal: BJC reports

Published: July 23, 2024

Real-world effectiveness of CDK 4/6 inhibitors in estrogen-positive metastatic breast cancer.

Real-world effectiveness of CDK 4/6 inhibitors in estrogen-positive metastatic breast cancer.

Journal: BJC reports

Published: May 14, 2024

Showing 1-12 of 93

Last Updated: 09/26/2026